BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 17164270)

  • 1. Evaluation of the radioactivity of the pre-dominant gamma emitters in components used at high-energy proton accelerator facilities.
    Numajiri M
    Radiat Prot Dosimetry; 2007; 123(4):417-25. PubMed ID: 17164270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement and analysis of induced activities in concrete irradiated using high-energy neutrons at KENS Neutron Spallation Source Facility.
    Oishi K; Nakao N; Kosako K; Yamakawa H; Nakashima H; Kawai M; Yashima H; Sanami T; Numajiri M; Shibata T; Hirayama H; Nakamura T
    Radiat Prot Dosimetry; 2005; 115(1-4):623-9. PubMed ID: 16381795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health physics aspects of neutron activated components in a linear accelerator.
    Guo S; Ziemer PL
    Health Phys; 2004 May; 86(5 Suppl):S94-S102. PubMed ID: 15069298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced radioactive nuclides of 10-MeV radiotherapy accelerators detected by using a portable HP-Ge survey meter.
    Fujibuchi T; Obara S; Yamaguchi I; Oyama M; Watanabe H; Sakae T; Katoh K
    Radiat Prot Dosimetry; 2012 Jan; 148(2):168-73. PubMed ID: 21317145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of induced radionuclides in low-activation concrete (limestone concrete) using the 12 GeV proton synchrotron accelerator facility at KEK.
    Saito K; Tanosaki T; Fujii H; Miura T
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):647-52. PubMed ID: 16604718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induced radioactivity in and around high-energy particle accelerators.
    Vincke H; Theis C; Roesler S
    Radiat Prot Dosimetry; 2011 Jul; 146(4):434-9. PubMed ID: 21697180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activation of solid materials in a medical linear electron accelerator].
    Ewen K; Lauber-Altmann I
    Rontgenblatter; 1987 Jun; 40(6):185-90. PubMed ID: 3616427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multileaf shielding design against neutrons produced by medical linear accelerators.
    Rebello WF; Silva AX; Facure A
    Radiat Prot Dosimetry; 2008; 128(2):227-33. PubMed ID: 17569690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance heavy concrete as a multi-purpose shield.
    Mortazavi SM; Mosleh-Shirazi MA; Roshan-Shomal P; Raadpey N; Baradaran-Ghahfarokhi M
    Radiat Prot Dosimetry; 2010 Dec; 142(2-4):120-4. PubMed ID: 21036811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation protection aspects of a 4 MW target.
    Agosteo S; Magistris M; Silari M
    Radiat Prot Dosimetry; 2005; 115(1-4):465-9. PubMed ID: 16381768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual monitoring for external radiation at accelerator facilities.
    Tanner RJ; Hager LG
    Radiat Prot Dosimetry; 2011 Jul; 146(4):395-402. PubMed ID: 21890527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between radioactivity induced inside the treatment room and the undesirable thermal/resonance neutron radiation produced by linac.
    Konefał A; Orlef A; Dybek M; Maniakowski Z; Polaczek-Grelik K; Zipper W
    Phys Med; 2008 Dec; 24(4):212-8. PubMed ID: 18339569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenth value layers for 60Co gamma rays and for 4, 6, 10, 15, and 18 MV x rays in concrete for beams of cone angles between 0 degrees and 14 degrees calculated by Monte Carlo simulation.
    Jaradat AK; Biggs PJ
    Health Phys; 2007 May; 92(5):456-63. PubMed ID: 17429304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The TRADE experiment: shielding calculations for the building hosting the subcritical system.
    Burn KW; Carta M; Casalini L; Kadi Y; Monti S; Nava E; Palomba M; Petrovich C; Picardi L; Rubbia C; Troiani F
    Radiat Prot Dosimetry; 2005; 115(1-4):187-94. PubMed ID: 16381710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting induced radioactivity for the accelerator operations at the Taiwan Photon Source.
    Sheu RJ; Jiang SH
    Health Phys; 2010 Dec; 99(6):788-99. PubMed ID: 21068597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation safety management of residual long-lived radioactivity distributed in an inner concrete wall of a medical cyclotron room.
    Yamaguchi I; Kimura K; Fujibuchi T; Takahashi Y; Saito K; Otake H
    Radiat Prot Dosimetry; 2011 Jul; 146(1-3):167-9. PubMed ID: 21498855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of correlation between radioactivity and exposure rate of irradiated concrete and stainless steel].
    Nakamura T; Hara A
    Radioisotopes; 1983 Dec; 32(12):602-8. PubMed ID: 6676778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gamma activity and radiation dose in concrete building blocks used for construction of dwellings in Jos, Nigeria.
    Ademola JA; Farai IP
    Radiat Prot Dosimetry; 2006; 121(4):395-8. PubMed ID: 16702239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiological protection evaluation of the Bucharest Tandetron 3 MV accelerator.
    Mitu IO; Floare G; Ghiţă DG; Moşu DV; Căta-Danil G
    J Radiol Prot; 2015 Jun; 35(2):285-95. PubMed ID: 25826271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Intensity Proton Accelerator Project in Japan (J-PARC).
    Tanaka S
    Radiat Prot Dosimetry; 2005; 115(1-4):33-43. PubMed ID: 16381679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.